ProQR Therapeutics (PRQR) Accounts Payables (2021 - 2024)
Historic Accounts Payables for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $17097.5.
- ProQR Therapeutics' Accounts Payables fell 9896.88% to $17097.5 in Q4 2024 from the same period last year, while for Dec 2024 it was $17097.5, marking a year-over-year decrease of 9896.88%. This contributed to the annual value of $17317.4 for FY2024, which is 9896.11% down from last year.
- ProQR Therapeutics' Accounts Payables amounted to $17097.5 in Q4 2024, which was down 9896.88% from $1.7 million recorded in Q4 2023.
- ProQR Therapeutics' 5-year Accounts Payables high stood at $1.7 million for Q4 2023, and its period low was $331.71 during Q1 2021.
- Moreover, its 4-year median value for Accounts Payables was $332378.9 (2021), whereas its average is $492730.4.
- In the last 5 years, ProQR Therapeutics' Accounts Payables soared by 27869549.4% in 2022 and then tumbled by 9896.88% in 2024.
- ProQR Therapeutics' Accounts Payables (Quarter) stood at $218498.5 in 2021, then soared by 83.04% to $399936.9 in 2022, then skyrocketed by 314.57% to $1.7 million in 2023, then tumbled by 98.97% to $17097.5 in 2024.
- Its last three reported values are $17097.5 in Q4 2024, $1.7 million for Q4 2023, and $127365.1 during Q3 2023.